logo
Haus
Über us
Unternehmensprofil
fabrik-ausflug
qualitätskontrolle
produits

Zellulose-Derivate

Stärke-Derivate

Tablettenschicht

anorganisches Salz

Pharmazeutische Zuckerkugeln

Harzreihe

Pharmazeutische Bindemittel

Siliciumdioxid

Magnesium-Stearat

CMC-Carboxymethylzellulose

Natriumstärke Glycolate

HPMC für Hypromellose

Mikrokristalline Zellulose MCC

Säurebehandelte Stärke

Zusammengesetztes Beschichtungsmittel

Zusammengesetzte Verdickungsmittel
video
ereignisse
neuigkeiten
rechtssachen
treten sie mit uns in verbindung
Plaudern Sie Jetzt
english
français
Deutsch
Italiano
Русский
Español
português
Nederlandse
ελληνικά
日本語
한국
العربية
हिन्दी
Türkçe
indonesia
tiếng Việt
ไทย
বাংলা
فارسی
polski
haus
Über us
produits

Zellulose-Derivate

Stärke-Derivate

Tablettenschicht

anorganisches Salz

Pharmazeutische Zuckerkugeln

Harzreihe

Pharmazeutische Bindemittel

Siliciumdioxid

Magnesium-Stearat

CMC-Carboxymethylzellulose

Natriumstärke Glycolate

HPMC für Hypromellose

Mikrokristalline Zellulose MCC

Säurebehandelte Stärke

Zusammengesetztes Beschichtungsmittel

Zusammengesetzte Verdickungsmittel
video
ereignisse
neuigkeiten
rechtssachen
treten sie mit uns in verbindung
Zitat
Banner Banner

NACHRICHTEN-DETAILS
Haus > Neuigkeiten >

Firmennachrichten über Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection

Ereignisse

Neuigkeiten

Rechtssachen
Treten Sie Mit Uns In Verbindung
Ms. Haileeping
haileeping@sunhere-excipients.com
86-0554-2796186
Kontakt jetzt

Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection

2026-02-05

Major Announcement: Sunhere Pharmaceutical Excipients Successfully Passes U.S. FDA On-Site Inspection, 

Marking Another Milestone in Its Global Layout!


The company has successfully completed the U.S. FDA on-site inspection and received the official Establishment Inspection Report (EIR) confirmation!


neueste Unternehmensnachrichten über Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection 0


This inspection covered the entire system, including quality management, production, facilities and equipment, quality control, and materials management. It marks the first time the company has obtained this authoritative FDA qualification. This not only signifies that Sunhere Pharmaceutical Excipients' GMP management system fully aligns with top international standards, but also means its products hold the core passport to enter the global market.


neueste Unternehmensnachrichten über Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection 1


As a leading domestic manufacturer of oral solid dosage form pharmaceutical excipients, Sunhere Pharmaceutical Excipients has continuously consolidated its global competitive barriers. Moving forward, the company will empower global customers with higher standards, advance the domestic substitution of pharmaceutical excipients, and accelerate its expansion into the global pharmaceutical ecosystem!

Banner
NACHRICHTEN-DETAILS
Haus > Neuigkeiten >

Firmennachrichten über-Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection

Ereignisse

Neuigkeiten

Rechtssachen

Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection

2026-02-05

Major Announcement: Sunhere Pharmaceutical Excipients Successfully Passes U.S. FDA On-Site Inspection, 

Marking Another Milestone in Its Global Layout!


The company has successfully completed the U.S. FDA on-site inspection and received the official Establishment Inspection Report (EIR) confirmation!


neueste Unternehmensnachrichten über Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection 0


This inspection covered the entire system, including quality management, production, facilities and equipment, quality control, and materials management. It marks the first time the company has obtained this authoritative FDA qualification. This not only signifies that Sunhere Pharmaceutical Excipients' GMP management system fully aligns with top international standards, but also means its products hold the core passport to enter the global market.


neueste Unternehmensnachrichten über Breakthrough: Sunhere Pharmaceutical Excipients Clears U.S. FDA On-Site Inspection 1


As a leading domestic manufacturer of oral solid dosage form pharmaceutical excipients, Sunhere Pharmaceutical Excipients has continuously consolidated its global competitive barriers. Moving forward, the company will empower global customers with higher standards, advance the domestic substitution of pharmaceutical excipients, and accelerate its expansion into the global pharmaceutical ecosystem!

Schnelle Verbindung
Haus ÜBER US Produits Video Neuigkeiten Rechtssachen Treten Sie mit uns in Verbindung
Schnelle Kontaktaufnahme

Adresse

Wirtschafts- und technologische Entwicklungszone,HUAINAN,ANHUI 232007,CHINA

Telefon

86-0554-2796186

Unser Newsletter
Abonnieren Sie unseren Newsletter für Rabatte und mehr.
Privacy policy |  Sitemap  | Gute Qualität Chinas Zellulose-Derivate Lieferant. Copyright-© 2024-2026 Anhui Sunhere Pharmaceutical Excipients Co., Ltd. . Alle Rechte vorbehalten.